1800 202 8726
Genetic test results

Variant of Unknown Significance — What a VUS Result Actually Means

A VUS is not a positive result and not a negative one. It is a genetic change your laboratory found but does not yet have enough evidence to classify. Most families who receive this result have no idea what to do next, and that uncertainty is the real problem this page addresses.

Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026

  • Not a diagnosis — A VUS does not mean you have cancer, nor that you are certain to develop it.
  • Not actionable yet — Clinical guidelines do not support changing treatment or surveillance based on a VUS alone.
  • Not permanent — VUSs are regularly reclassified as evidence accumulates. Among those reclassified, most become benign.
  • Not a reason to test relatives — Cascade family testing is only meaningful once a variant is confirmed pathogenic, not while it is a VUS.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

A variant of unknown significance, or VUS, is a genetic change where scientists do not yet have enough evidence to say whether it raises cancer risk. It is not a positive result. It does not mean you have cancer, and ACMG and ASCO guidelines do not support changing treatment or surveillance based on a VUS alone.

What do the words on your report actually mean?

Variant of Unknown Significance (VUS)
A change in one of your genes where the scientific evidence is not yet strong enough to say whether it raises cancer risk or not. It sits between a pathogenic variant and a benign one — a genuine grey zone, not a clerical error or a near-miss.
Pathogenic variant
A genetic change that is known, with strong evidence, to increase the risk of a specific cancer. This is what people mean when they say a genetic test came back positive for a risk gene.
Benign variant
A genetic change that has been studied enough to confirm it does not increase cancer risk. Most genetic variants found in the general population are benign.
Reclassification
The process by which a VUS is moved to pathogenic or benign as more evidence accumulates. It can happen months or years after your test, and the laboratory that performed your test is expected to inform you when it does.
ClinVar
A free, publicly accessible database run by the US National Institutes of Health where laboratories worldwide submit their variant findings. It is the primary resource geneticists use to track whether a VUS has been reclassified anywhere in the world.

What to do — and not do — when your result says VUS

  • Keep a copy of your full genetic report, not just the summary letter.
  • Tell your oncologist the result before making any decision about your care.
  • Do not change your treatment plan, surveillance schedule, or surgery plans based on a VUS alone.
  • Do not advise family members to rush into genetic testing based on this result. Family testing is only meaningful once a variant is confirmed pathogenic.
  • Ask your genetic counsellor whether the laboratory will notify you automatically if the classification changes.
  • Tell your care team about any family members newly diagnosed with cancer — new diagnoses add to the evidence pool and may help reclassify your VUS.

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

Will a VUS always stay a VUS?

No. Reclassification is the normal trajectory, and among VUSs that are eventually reclassified, the majority move to benign rather than pathogenic.

Evidence accumulates as more families contribute their data to international databases such as ClinVar. A variant recorded by only a handful of laboratories is harder to classify than one with data from thousands of families worldwide.

ACMG guidelines require laboratories to re-evaluate their VUS classifications as evidence evolves. More commonly seen variants tend to be reclassified faster; rare variants in less-studied genes can remain a VUS for years.

Ask your genetic counsellor whether your laboratory will contact you automatically if your classification changes, and if not, what the process is for checking.

Questions your family is probably asking

Does a VUS mean my children or siblings need genetic testing?

Not yet. Cascade testing — where relatives are offered a test based on a result in the family — is only recommended after a pathogenic variant has been identified. Testing a relative for a VUS produces a result that is equally uninterpretable for them: they would also receive a VUS report, and neither of you would be any clearer about risk. ACMG guidance recommends waiting for reclassification before testing relatives, unless there are other independent clinical reasons to test them separately.

Could a VUS affect my insurance in India?

India's legal protections against genetic discrimination are still developing, and the regulatory landscape around disclosure of genetic results to insurers is not yet clearly defined. A VUS is not a diagnosis and does not confirm elevated cancer risk, but how an insurer interprets the paperwork can vary. If you are concerned, speak with a genetic counsellor before sharing any genetic report with a third party. Your oncologist and counsellor can advise on what must be disclosed and what does not.

How long before a VUS is reclassified?

There is no fixed timeline, and anyone who gives you one is guessing. A variant seen frequently across many families in shared databases may be reclassified within months. A rare variant in a gene that is not yet well studied may remain a VUS for years, or indefinitely. The honest answer from any reputable laboratory is that they do not know. What they can tell you is how frequently they review their classifications and whether they will contact you when a change happens.

Should I get a second opinion on the VUS interpretation?

It is reasonable to ask. Different laboratories use the same international criteria — the ACMG and AMP classification framework — so a second interpretation of a clearly documented VUS is unlikely to produce a different classification. Where a second look is more useful is when the report is unclear, when the gene itself is disputed, or when the clinical picture does not match the result. A genetic counsellor can advise whether a second interpretation is worthwhile in your specific case.

Does a VUS change my cancer treatment?

No. A VUS does not tell your oncologist that a specific treatment will or will not work for your cancer. Treatment decisions are based on your tumour's characteristics, your stage, and the established standard of care for your diagnosis. If you had a confirmed pathogenic variant in certain genes, that can sometimes influence specific treatment decisions — but that is a categorically different result from a VUS. Your oncologist will explain what, if anything, your genetic results mean for your current treatment plan.

Did you know?

Among VUS results that are eventually reclassified, published analyses of the ClinVar database consistently show that the majority move to benign rather than pathogenic.

This does not mean your specific VUS is harmless — it means that at a population level, reclassification most often brings reassuring news. Your own result needs to be tracked individually.

Source: ClinVar / American College of Medical Genetics and Genomics (ACMG)

Explore 112 more Markers, Molecular Testing and Test Accuracy topics

HUB — How Accurate Is a Biopsy? Repeats, Errors and Second Opinions

HUB — IHC and Molecular Markers on a Biopsy

HUB — Labs, Slides and Second Opinions on a Biopsy

All Markers, Molecular Testing and Test Accuracy →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

What is the difference between a VUS and a positive genetic test?

A positive genetic test means a pathogenic variant was found — a change known, with strong evidence, to increase the risk of a specific cancer. A VUS is different: it is a change where that evidence does not yet exist. The two results lead to completely different next steps. A pathogenic result triggers recommendations for surveillance, preventive discussions, or cascade family testing. A VUS does not trigger any of those actions on its own. If your report uses the words 'positive' and 'VUS' in the same document, ask your genetic counsellor which result is driving the recommendation.

My report says VUS — does that mean I have a higher cancer risk?

Not based on that result alone. A VUS means the evidence is insufficient to say either way — not that the evidence points toward higher risk. Living with that ambiguity is genuinely uncomfortable, and the discomfort is understandable. What you can do is tell your oncologist, make sure your full clinical picture is being considered, and ask to be notified if the classification changes. Your risk assessment should be based on your personal and family history alongside any confirmed findings — not on the VUS alone.

Can I do anything to help get my VUS reclassified faster?

Yes, in a limited way. Sharing your data with research registries and variant databases, with your consent, contributes to the evidence pool that laboratories and researchers use to reclassify variants. Ask your genetic counsellor whether your laboratory participates in data-sharing programmes and whether you can opt in. Keeping your care team updated about new cancer diagnoses in your family is also useful — family data is one of the inputs laboratories rely on. Neither action guarantees a faster outcome, but both contribute to the process.

The laboratory said to come back in a year to check. Is that normal?

Yes. Annual or periodic re-evaluation is standard practice for VUSs, and some laboratories do this proactively while others expect you to follow up. The important thing is to have a clear plan for who will check and how you will be notified. Ask your genetic counsellor to clarify: does the laboratory re-evaluate automatically, will they contact you, or do you need to request a re-check? Do not assume a year of silence means the classification has been resolved.

My doctor says not to worry. Why did the test cost so much if the result is unclear?

Your doctor's reassurance is clinically appropriate — a VUS genuinely does not warrant action on its own, and not worrying is the right response to an unactionable result. The cost reflects the complexity of sequencing and interpretation, not the clarity of the answer. Genomic testing often surfaces ambiguity alongside useful findings, and a VUS in one gene may coexist with clear, actionable findings elsewhere in your report. Ask your oncologist to walk you through the full report so you understand what it did and did not find.

What should I tell my family about my VUS result?

Tell them that a genetic variant was found but that it is currently unclassified — meaning science does not yet know whether it has any significance. Reassure them that this result does not mean you have a hereditary cancer condition, and that no one in the family needs to rush into testing based on this alone. If family members are worried, suggest they speak with your genetic counsellor directly. The counsellor can explain the result in context and advise whether any family history warrants independent genetic evaluation.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation